Being told you may have lung cancer, or that lung cancer has been confirmed, can feel overwhelming. Many people describe this moment as frightening, confusing and difficult to process. You may have many questions at once: How serious is it? Has it spread? What treatment will I need? How quickly will things happen?
The most important thing to know is that a diagnosis is not the end of the conversation. It is the beginning of a more detailed process to understand the type of lung cancer, its stage, its biological features and the most appropriate treatment options for you.
Topics Covered
Topics Covered
Topics Covered
Topics CoveredQuick answer: what usually happens after a lung cancer diagnosis?
After a lung cancer diagnosis, your medical team will usually gather more information about the cancer. This may include scans, biopsy results, staging, molecular or biomarker testing, and discussion by a specialist multidisciplinary team. These steps help doctors understand the type of lung cancer and recommend the most suitable treatment plan.
Key takeaways
- A lung cancer diagnosis is usually followed by further tests to understand the type and stage of the cancer.
- The stage shows whether the cancer is localised, locally advanced or has spread to other parts of the body.
- Biopsy and biomarker results can help guide treatment decisions, especially in non-small cell lung cancer.
- Your case is often discussed by a lung cancer multidisciplinary team, known as an MDT.
- Treatment may include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy or a combination of treatments.
Take a moment before trying to understand everything
It is completely normal not to take in everything at the first appointment. Many patients remember only part of what was said. Some people feel shocked, numb or anxious. Others immediately want to research every detail.
There is no “right” way to respond.
It can help to:
- write down your questions,
- bring someone with you to appointments,
- ask your doctor to repeat or explain anything unclear,
- request written information where possible,
- avoid relying only on online searches, especially before your full results are available.
At this stage, the aim is not to understand every possible treatment. The aim is to understand the next step.
Step 1: Confirming the type of lung cancer
Lung cancer is not one single disease. The two main groups are:
- Non-small cell lung cancer, often shortened to NSCLC.
- Small cell lung cancer, often shortened to SCLC.
This distinction matters because the treatments and behaviour of the disease can be different.
Doctors usually confirm the type of lung cancer through a biopsy, where a small sample of tissue is examined by a specialist pathologist. In some cases, additional tests are needed to get enough information from the tumour sample.
Step 2: Understanding the stage
Staging means finding out where the cancer is and whether it has spread.
Your doctors may use scans such as CT, PET-CT, MRI or other investigations depending on your situation. The stage helps guide whether treatment is aimed at removing or controlling disease in one area, treating cancer that has spread, or combining different types of treatment.
In simple terms, lung cancer may be described as:
- early-stage, when it appears more localised,
- locally advanced, when it involves nearby lymph nodes or structures,
- advanced or metastatic, when it has spread to more distant parts of the body.
Staging is one of the most important parts of treatment planning. Two people with the same type of lung cancer may need very different treatments if their stage is different.
Step 3: Biomarker and molecular testing
For many people with non-small cell lung cancer, especially advanced NSCLC, doctors may test the cancer for specific biomarkers or genetic changes within the tumour.
These are not usually inherited genetic tests. They look at changes within the cancer cells themselves.
These tests may include markers such as:
The results may help doctors decide whether targeted therapy, immunotherapy, chemotherapy or a combination may be appropriate.
This is one reason why treatment does not always start immediately on the same day as diagnosis. In some cases, waiting for the right test results can help doctors choose a more suitable first treatment.
Step 4: Your case may be discussed by a specialist MDT
Many lung cancer cases are discussed in a multidisciplinary team meeting, often called an MDT.
This is a meeting where different specialists review the case together. Depending on the situation, the team may include:
- medical oncologists,
- respiratory physicians,
- thoracic surgeons,
- radiologists,
- pathologists,
- clinical oncologists,
- lung cancer nurse specialists,
- palliative care specialists, where appropriate.
The purpose of the MDT is to bring different expertise together before recommending a treatment plan. This is especially important when decisions are complex, when more than one treatment option may be possible, or when specialist review is needed.
You usually do not attend the MDT meeting yourself, but your doctor or clinical team should explain the outcome and recommended next steps.
Step 5: Discussing treatment options
Treatment depends on several factors, including:
- the type of lung cancer,
- the stage,
- biopsy and biomarker results,
- your general health,
- your lung function,
- previous medical conditions,
- your preferences and goals of care.
Treatment may include one or more of the following:
- Surgery
Often considered when lung cancer is localised and the patient is fit enough for an operation. - Radiotherapy
Can be used in early-stage disease, locally advanced disease, symptom control or selected metastatic situations. - Chemotherapy
Still plays an important role in many lung cancer treatment plans. - Immunotherapy
A treatment that helps the immune system recognise and attack cancer cells. - Targeted therapy
Tablets or other medicines that target specific changes in cancer cells. - Chemoradiotherapy
A combination of chemotherapy and radiotherapy, often used in selected locally advanced cases.
Some people will have one main treatment. Others may need a sequence or combination of treatments.
Why treatment plans can differ between patients
It is very common for patients to compare their diagnosis with someone else’s. This is understandable, but it can also be misleading.
Two people may both have “lung cancer” but have very different:
- cancer types,
- stages,
- biomarker results,
- symptoms,
- scan findings,
- treatment options,
- general health considerations.
This is why personalised treatment planning is so important. The best treatment is not simply the newest treatment. It is the treatment that best fits the clinical situation.
Questions you may want to ask your oncologist
You do not need to ask everything at once. But these questions can help you feel more prepared:
- What type of lung cancer do I have?
- What stage is it?
- Has the cancer spread anywhere else?
- Do we have all the biopsy and biomarker results?
- Will my case be discussed by an MDT?
- What treatment options are available?
- Is the aim of treatment to cure, control or relieve symptoms?
- What are the possible side effects?
- How soon do I need to start treatment?
- Who should I contact if I feel worse or have urgent concerns?
It may help to take these questions to your appointment and make notes during the discussion.
Looking after yourself emotionally
A lung cancer diagnosis affects more than the body. It can affect your sleep, appetite, relationships, work and sense of control.
Many patients feel pressure to “stay positive”, but it is also normal to feel scared or upset. Support can come from different places, including:
- your clinical nurse specialist,
- your oncology team,
- your GP,
- family and friends,
- counselling or psychological support,
- cancer support organisations.
Asking for support is not a sign of weakness. It is part of cancer care.
When to seek specialist advice or a second opinion
Some patients seek specialist advice when:
- the diagnosis is complex,
- they have been told there is more than one possible treatment option,
- they want to understand biomarker or molecular results,
- they have advanced or metastatic lung cancer,
- they are considering private oncology care,
- they would like another specialist review of their treatment plan.
A second opinion does not necessarily mean changing doctors or changing treatment. Sometimes it helps confirm that the plan is appropriate. In other cases, it may identify additional questions, tests or treatment options to discuss.
A specialist perspective
In modern lung cancer care, the diagnosis is only one part of the picture. Treatment decisions increasingly depend on detailed information from scans, biopsy, pathology, molecular testing and MDT discussion.
For patients, this process can feel like waiting. Clinically, however, these details can be essential. They help the oncology team avoid a “one-size-fits-all” approach and move towards a more personalised treatment recommendation.
The most useful first step is to make sure the diagnosis, stage and test results are fully understood before deciding on treatment.
Final thoughts
Being diagnosed with lung cancer is life-changing, but you do not need to understand everything immediately. Your medical team should guide you through each stage of the process.
The next steps usually involve confirming the cancer type, understanding the stage, reviewing biopsy and biomarker results, discussing the case in a specialist team and then agreeing on a treatment plan.
Clear information, specialist input and careful planning can help you feel more informed and more supported as you move forward.
Support and Follow-Up Care
Dr Papadatos-Pastos and his team provide ongoing support beyond medical treatment.
Patients receive clear communication, psychological care and access to nutrition, physiotherapy and symptom-management services.
Regular follow-up ensures early detection of recurrence and long-term wellbeing.
Book a Consultation
If you or someone close to you has been diagnosed with lung cancer, early consultation with a specialist can make a real difference. Appointments are available at several London clinics.
Faq
Answers to Common Questions
Answers to common questions about what happens after a lung cancer diagnosis, including staging, biopsy results, MDT review and treatment planning.
Doctors usually confirm the type of lung cancer, assess the stage and review biopsy or scan results. In many cases, the next step is discussion by a specialist multidisciplinary team and treatment planning.
Sometimes treatment starts quickly, but in many cases doctors need full staging, pathology and biomarker results first. This helps them choose the most appropriate treatment.
Staging describes where the cancer is, how large it is and whether it has spread. It is one of the key factors that guides treatment decisions.
Many patients with non-small cell lung cancer, especially advanced NSCLC, may have biomarker or molecular testing. These results can help guide targeted therapy or immunotherapy decisions.
A lung cancer MDT is a multidisciplinary team of specialists who review diagnosis, scans, biopsy results and treatment options together before making treatment recommendations.
Yes. Lung cancer treatment depends on the type, stage and individual patient factors. Treatment may aim to cure, control the cancer, slow its growth or relieve symptoms.
A second opinion can be helpful if your diagnosis is complex, you want to understand your options more clearly, or you would like a specialist review of your treatment plan.
References / Further Reading
- NHS England — Implementing a timed lung cancer diagnostic pathway
https://www.england.nhs.uk/long-read/implementing-a-timed-lung-cancer-diagnostic-pathway/ - NICE — Lung cancer: diagnosis and management
https://www.nice.org.uk/guidance/ng122 - Cancer Research UK — Tests for lung cancer
https://www.cancerresearchuk.org/about-cancer/lung-cancer/getting-diagnosed/tests-for-lung-cancer - Cancer Research UK — Treatment for lung cancer
https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment - Cancer Research UK — Treatment options for non-small cell lung cancer
https://www.cancerresearchuk.org/about-cancer/lung-cancer/treatment/non-small-cell-lung-cancer
